Toxic-shock Syndrome Complicating Recovery from Elective Cholecystectomy

Todd J. , Fishaut M. , Kapral F. , Welch T. Toxic-shock syndrome associated with phage-group-I staphylococci. Lancet 1978; 2: 1116–1118.

Tofte R.W. , Williamson D.N. Toxic shock syndrome: clinical and laboratory features in 15 patients. Ann Intern Med 1981; 94: 149–156.

Shands K.N. , Schmid G.P. , Dan B.B. , Blum D. , Guidotti R.J. , Hargrett N.T. , Anderson R.L. , Hill D.L. , Broome C.V. , Band J.D. , Fraser D.W. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med 1980; 303: 1436–1442.

Fisher R.F. , Goodpasture H.C. , Peterie J.D. , Voth D.W. Toxic-shock syndrome in menstruating women. Ann Intern Med 1981; 94: 156–163.

Centre for Disease Control: Toxic-Shock syndrome — United States. Morbid Mortal Weekly Rep 1980; 29: 229–230.

Centre for Disease Control: Follow-up on toxic-shock syndrome. Morbid Mortal Weekly Rep 1980; 29: 441–445.

Bergdoll M.S. , Crass B.A. , Reiser R.F. , Robbins R.N. , Davis J.P. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock syndrome Staphylococcus aureus isolates. Lancet 1981; 1: 1017–1021.

Stevens F.A. The occurrence of Staphylococcus aureus infection with a scarlatiniform rash. JAMA 1927; 88: 1957–1958.

Arznow H. , Wood W.B. Staphylococcic infection simulating scarlet fever. JAMA 1942; 119: 1491–1495.

David J.B. , Chesney P.J. , Wand P.J. , La Venture M. Toxic-shock syndrome: epidemiologic features, recurrence, rash factors and prevention. N Engl J Med 1980; 303: 1429–1435.

Center for Disease Control: Follow-up on toxic-shock syndrome — United States. Morbid Mortal Weekly Rep 1980; 29: 297–299.

Jacob H.S. Granulocyte-complement interaction: a beneficial antimicrobial mechanism that can cause disease. Arch Intern Med 1978; 138: 461–463.